News
Notices from medicines regulators and headlines from health, pharma and biotech journalism worldwide — only those about a catalog substance or about peptides in general. Every item links to the original.
- HHS to allow compounders to make 6 unapproved peptides
- STAT+: El-Sayed claps back at RFK Jr., and FDA’s ‘enforcement discretion’ on peptides
- STAT+: HHS green lights six peptides, despite concerns from FDA scientists
- STAT+: Pharmalittle: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and more
- STAT+: HHS moves to allow compounding of some unapproved peptides
- Lilly’s ‘triple-G’ drug tops Novo’s Ozempic in diabetes trial
- STAT+: Lilly’s triple-G drug beats Ozempic in head-to-head study
- STAT+: Lilly says ‘triple-G’ drug beat Novo’s Ozempic in diabetes study
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026
Agency summary (EMA): Six new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended six medicines for approval at its October 2026 meeting. Rasonque (daraxonrasib)…
- Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels
No items of this type yet.
No items of this type yet.
Sources we monitor
Items are picked automatically when a headline or feed summary names a catalog substance; official notices about peptides in general are also kept, and media stories when the headline itself is about peptides. Media items show only the headline, outlet, date and link. How items are selected
- FDA · Press announcements
- FDA · MedWatch safety alerts
- FDA · What's new: drugs
- FDA · Recalls, market withdrawals and safety alerts
- FDA · Health fraud
- EMA · News and press releases
- AEMPS · Noticias y notas informativas
- TİTCK · Duyurular
- STAT
- STAT · Pharma
- STAT · Biotech
- BioPharma Dive
- KFF Health News
- The Conversation · Health
- Redacción Médica
- ConSalud
- The Conversation · Salud
- TRT Haber · Sağlık